Arivin Therapeutics
PrivateLast Round
Grant
Jan 22, 2026
Total Funding Raised
$3.51M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Arivin Therapeutics is a biotechnology company that develops antimicrobial therapies to treat drug-resistant bacterial infections by targeting bacterial toxins and biofilms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arivin Therapeutics Comparables
Compare Arivin Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zaluvida Ventures | 80% | |
| ProclaRx LLC | 79% | |
| AlgiPharma AS | 79% | |
Arivin Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 22, 2026 | ||||
| Seed | Aug 28, 2025 | ||||
| Accelerator | Jan 27, 2022 |
Arivin Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SPARK Finland | Accelerator |
| INCATE | Accelerator |
| Business Finland | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 349% MoM.
- Jan 22, 2026
$440K grant received from Business Finland.
Arivin Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arivin Therapeutics's valuation, stock price, and market status.